Mousinho Filipa, Mendes Tatiana, Sousa E Santos Paula, Acosta Maria João, Pereira José, Arroz Maria, Silva Cândido, Azevedo Ana Paula, Oliveira Rita, Chorão Martinha, Lima Fernando
Clinical Hematology Department, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
Clinical Pathology Department, Flow Cytometry Laboratory, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
Case Rep Hematol. 2018 May 27;2018:7817918. doi: 10.1155/2018/7817918. eCollection 2018.
Early-stage chronic lymphocytic leukemia (CLL) with neurologic involvement is a rare condition and should require a careful follow-up. Although no standard protocol exists for this condition, intrathecal chemotherapy, combined with systemic chemoimmunotherapy, has been used previously. This case describes the treatment of a patient with CLL and symptomatic compromise of the central nervous system. Our results suggest that a combination of chemotherapy, radiotherapy, and ibrutinib, administered sequentially over a 2-year period, led to a near-complete resolution of the cerebral spinal fluid neoplastic infiltration. Importantly, this response has been maintained with ibrutinib monotherapy for more than 12 months.
伴有神经受累的早期慢性淋巴细胞白血病(CLL)是一种罕见疾病,需要仔细随访。尽管针对这种情况尚无标准方案,但鞘内化疗联合全身化学免疫疗法此前已被应用。本病例描述了一名患有CLL且中枢神经系统出现症状性损害患者的治疗情况。我们的结果表明,在2年时间内序贯给予化疗、放疗和伊布替尼,导致脑脊液肿瘤浸润几乎完全消退。重要的是,伊布替尼单药治疗已维持这种反应超过12个月。